Chronic kidney disease: open trials in Slovakia

• NCT06742723

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  Trial Treatment · Phase 3 · AstraZeneca

  Smolko s.r.o., Kosice · Nemocnica S Poliklinikou Myjava So Sidlom V Myjave, Myjava · InterStom, s.r.o., Nitra · Leamed s.r.o., Presov · BIODIAL spol. s r.o., Púchov · Fakultna nemocnica Trencin, Trenčín · Fakultna nemocnica Trnava, Trnava · Medivasa s.r.o., Žilina

  Registry updated 2026-11-06

• NCT07241390

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Diacrin s.r.o., Bratislava · B. Braun Avitum s.r.o., Galanta · INTERN, s. r. o., Ilava · Medispektrum s.r.o., Petrzalka · B. Braun Avitum s.r.o., Pezinok · Dentavia s.r.o., Poprad · SPAOLO, s. r. o., Stará Turá · MUDr. Žáková s.r.o., Trenčín · B. Braun Avitum s.r.o., Trstena · DIA MED CENTRUM s.r.o., Zilina · Medivasa s.r.o., Žilina

  Registry updated 2026-11-04

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  FMC - dialyzacne sluzby, s.r.o., Košice

  Registry updated 2026-10-05

• NCT05485961

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Trial Treatment · Phase 2/3 · CSL Behring

  Nefrologicka ambulancia Levice - FMC dialyzacne sluzby, s.r.o., Levice · LC-REN s.r.o., Lučenec · Biodial, s.r.o., Púchov

  Registry updated 2026-09-21

• 2023-503634-50-01

  Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis

  Trial Treatment · Phase 3 · Genexine Inc.

  B. Braun Avitum s.r.o., Bratislava · B. Braun Avitum s.r.o., Galanta · B. Braun Avitum s.r.o., Pezinok · BIODIAL spol. s r.o., Púchov · B. Braun Avitum s.r.o., Sala · Nemocnica AGEL Zvolen a.s., Zvolen

  Registry updated 2026-09-15

• NCT07750249

  The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome.

  Trial Treatment · Early phase 1 · University Hospital, Martin

  University Hospital Martin, Martin

  Registry updated 2026-08-06

• NCT07338929

  Physical Performance Assessment in Kidney Transplant Evaluation

  Research · University Hospital, Martin

  Transplant-nephrology department, Martin

  Registry updated 2026-01-14

• NCT06801886

  Silymarin's Advantage on Graft Effectiveness

  Trial Treatment · Phase 3 · University Hospital, Martin

  This trial only enrols participants who have had an organ transplant

  University Hospital Martin, Martin

  Registry updated 2025-03-30

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error